Literature DB >> 18156505

Continue to study childhood ALL.

Mary V Relling, William E Evans, Ching-Hon Pui.   

Abstract

Mesh：

Year:  2008        PMID： 18156505      PMCID： PMC2200825          DOI： 10.1182/blood-2007-08-109025

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

2.  Genome-wide association. Closing the net on common disease genes.

Authors:  Jennifer Couzin; Jocelyn Kaiser
Journal:  Science       Date:  2007-05-11       Impact factor: 47.728

3.  Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Authors:  Bruce C Bostrom; Martha R Sensel; Harland N Sather; Paul S Gaynon; Mei K La; Katherine Johnston; Gary R Erdmann; Stuart Gold; Nyla A Heerema; Raymond J Hutchinson; Arthur J Provisor; Michael E Trigg
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

4.  Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Cheng Cheng; Wing Leung; Shesh N Rai; Gaston K Rivera; John T Sandlund; Raul C Ribeiro; Mary V Relling; Larry E Kun; William E Evans; Melissa M Hudson
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

5.  Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

Authors:  Allen R Chauvenet; Paul L Martin; Meenakshi Devidas; Stephen B Linda; Beverly A Bell; Joanne Kurtzberg; Jeanette Pullen; Mark J Pettenati; Andrew J Carroll; Jonathan J Shuster; Bruce Camitta
Journal:  Blood       Date:  2007-04-18       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.